Short Interest in Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Drops By 83.3%

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the recipient of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totalling 100 shares, a decrease of 83.3% from the June 30th total of 600 shares. Based on an average daily volume of 400 shares, the short-interest ratio is presently 0.3 days.

Hikma Pharmaceuticals Stock Performance

Shares of HKMPY remained flat at $49.33 during trading hours on Friday. The company had a trading volume of 48 shares, compared to its average volume of 902. The stock has a 50-day simple moving average of $49.62 and a two-hundred day simple moving average of $49.11. Hikma Pharmaceuticals has a twelve month low of $42.23 and a twelve month high of $56.63.

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.